Sorry, this entry is only available in 日本語.
|2011年||2011: Sawako Hanyu, Ph.D.President, Ochanomizu University
My tenure as representative of the consortium began in January 2011, taking over from Dr. Oyama from Tokyo Medical and Dental University.
I believe that well-trained individuals who receive superior secondary education in Japan are a vital resource in a country that has so few natural resources. They are the key to sustained growth and the ability to thrive in a global age. From that perspective, the university has a significant role to play and must try to respond to the mandate of the country’s citizens. One effective strategy is collaboration among universities wherein mutual contributions are made through the strengths and complementary academic areas of each university.
|2010年||2010:Dr. Takashi Oyama, President of Tokyo Medical and Dental University
The life sciences have seen explosive development since the last century, and their importance continues to grow in opening up new interdisciplinary areas and as a foundation for promoting new industries. Graduate school education in the life sciences provides the chance to acquire advanced knowledge, but researchers must learn to be aware of what scopes of research can be useful to society. Also, within a single university specializations are limited by the available areas of study. For these reasons it is necessary to have collaboration among universities in order to produce trained individuals who have the broad range of knowledge that is needed in society. The cooperation of regional research institutes and industry is also needed. The Tokyo Interdisciplinary Life Sciences Consortium was launched to take advantage of the complementary characteristics of four universities in the field of interdisciplinary life sciences and to provide coordination and crossover in four broad areas of research—the material life sciences linked to basic physical chemistry at Ochanomizu University; biomolecular science at Gakushuin University; biopharmaceutics geared toward drug discovery at Kitasato University; and disease prevention sciences linked to clinical medicine at Tokyo Medical and Dental University. Additionally, to create an exceptional “neighborhood” research institute and achieve collaboration with industry, the consortium is promoting the following four pursuits.